{"id":"NCT00877929","sponsor":"Boehringer Ingelheim","briefTitle":"Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus","officialTitle":"An 8-week Randomised, Double-blind Study to Compare the Fixed-dose Combination of Telmisartan 80 + Amlodipine 10mg Versus Amlodipine 10 mg Monotherapy as First Line Therapy in Type 2 Diabetes Patients With Hypertension.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2010-05","completion":null,"firstPosted":"2009-04-08","resultsPosted":"2011-06-07","lastUpdate":"2014-03-12"},"enrollment":706,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Telmisartan 80","otherNames":[]},{"type":"DRUG","name":"Amlodipine 10","otherNames":[]},{"type":"DRUG","name":"Amlodipine 10","otherNames":[]}],"arms":[{"label":"Telmisartan 80 / Amlodipine 10","type":"EXPERIMENTAL"},{"label":"Amlodipine 10","type":"ACTIVE_COMPARATOR"}],"summary":"To demonstrate that the fixed dose combination of telmisartan and amlodipine is more effective in lowering blood pressure.","primaryOutcome":{"measure":"Change From Baseline in Trough Seated Systolic Blood Pressure to Week 8","timeFrame":"Baseline, week 8","effectByArm":[{"arm":"Telmisartan 80 mg + Amlodipine 10 mg","deltaMin":-29,"sd":0.66},{"arm":"Amlodipine 10 mg","deltaMin":-22.9,"sd":0.67}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":65,"countries":["United States","Argentina","Mexico","Netherlands","Slovakia","South Africa","South Korea","Spain","Sweden"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":352},"commonTop":["Oedema peripheral"]}}